3 Important Laws that Protect Genetic Counseling Patients from Discrimination

Those who undergo genetic testing to learn about their cancer risk have several protections in place to ensure the results can’t be used against them.

7:00 AM

Author | Lauren Hipp, M.S., C.G.C.

Genetic counseling and testing plays an integral role for many patients at risk of developing cancer. The results can help them and their families determine what screening and treatment methods might be necessary.

By doing so, however, some people might also fear repercussions to their employment status or health care coverage.

Genetic discrimination occurs when employers or insurance companies treat people differently or deny them privileges or opportunities because of their genetic test results, family history information, a family member's genetic test results or other genetic data.

That's why state and federal laws have been enacted to help protect families from those circumstances.

Here is what three of them entail:

The Americans with Disabilities Act of 1990 (ADA): This federal law prohibits employment discrimination based on an individual's disability or perceived disability. This protection extends to those with a genetic condition or predisposition that limits daily life.

The Genetic Information Nondiscrimination Act of 2008 (GINA): This federal act prohibits the use of genetic information by employers when making decisions on hiring, firing and promotions. It also prevents health insurance companies from using genetic information when making decisions regarding coverage eligibility, rates and pre-existing conditions. The protections of this law, however, do not extend to life insurance, disability insurance or long-term care insurance coverage. They also do not extend to people who are already affected by a genetic condition (i.e., those who have symptoms or clinical manifestations of a condition).

The Affordable Care Act (ACA): This law provides additional protection by prohibiting health insurance discrimination based on pre-existing conditions, including genetic conditions.

New concerns

With ongoing efforts to repeal ACA as well as the recent introduction of a new bill, the Preserving Employee Wellness Programs Act (HR 1313), many patients have raised concerns.

The bill addresses the right of an employer to request and use an employee's health and genetic information as it pertains to enrollment in employer-sponsored wellness programs and disbursement of incentives for such programs. It does not take away the primary protection of GINA as it relates to health insurance eligibility or employment, nor does it obligate individuals to participate (although they would need to comply with health information requests if they chose to enroll).

The legislative process is ongoing, and multiple amendments to this bill — as well as position statements from multiple professional medical societies — are anticipated.

A personal decision

Despite anti-discrimination protections, the decision to undergo genetic testing and to subsequently share those results is personal and depends on multiple factors.

Your genetics health care team is available to help you address your concerns and navigate the benefits, risks and limitations of the genetic testing process to make the best decision for you and your family.

You can search for a genetic counselor near you through the National Society of Genetic Counselors, or call 734-763-2532 to make an appointment with the Cancer Genetics Clinic at the University of Michigan Comprehensive Cancer Center.


More Articles About:

Cancer Care Cancer and Genetics genetic counseling Genetic Testing Health Care Delivery, Policy and Economics Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Computer screens and microscope pictured in a laboratory setting.
Health Lab

Understanding family history key to early detection of pancreatic cancer

How genetic testing and family history help identify individuals at high risk for pancreatic cancer, enabling earlier screening and better treatment outcomes.
Michael Powers pictured here holding a fish he caught as he stands in a boat. He struggled with pancreatitis for several decades and found answers at University of Michigan Health.
Health Lab

Patient with rare form of diabetes finds answers in genetic testing, clinical trials

Discover how genetic testing and a groundbreaking clinical trial helped one man overcome rare hyperchylomicronemia, high triglycerides, and pancreatitis.
Three people stand arm in arm with backs to camera studying a wall of family mementos
Health Lab

Online resources and coaching helped people seek genetic testing for cancer

New study from researchers at the University of Michigan Rogel Cancer Center showed an online resource and phone-based coaching both helped increase rates of genetic testing.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.